Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | TACR1 | P25103 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 4/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4158069 | 0.76 | CES1 (0.46) | CES1TACR1HDAC1HDAC2 | |
| Trifluoroacetic Acid SCHEMBL4164876 | 0.75 | BCHE (0.42) | ACHE | |
| SCHEMBL4159627 | 0.74 | CES1 (0.47) | CES1OPRM1HDAC1HDAC2ALDH1A1 | |
| SCHEMBL4162820 | 0.73 | CES1 (0.42) | CES1HDAC1HDAC2ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL4164046 | 0.72 | SLC2A1 (0.40) | CES1KCNH2OPRM1 | |
| Trifluoroacetic Acid SCHEMBL4161040 | 0.71 | SIGMAR1 (0.43) | CES1KCNH2OPRM1 | |
| Trifluoroacetic Acid SCHEMBL4166752 | 0.70 | KCNH2 (0.39) | CES1KCNH2OPRM1 | |
| Trifluoroacetic Acid SCHEMBL4158032 | 0.70 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL4171428 | 0.69 | CES1 (0.44) | CES1HDAC1HDAC2 | |
| Trifluoroacetic Acid SCHEMBL4154008 | 0.69 | CHRM2 (0.38) | CES1KCNH2OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090054448-A1 | Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors | JONES PHILIP | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054448-A1 | Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors | HDAC5, HDAC1, HDAC11 | CES1 1925/4885KCNH2 3380/4885HRH3 315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.